Newsroom

Sorted by: Latest

-

Peachtree Group Equipment Finance Division Posts Strong Early Momentum and Expands Platform for 2026

ATLANTA--(BUSINESS WIRE)--Peachtree Group's Equipment Finance division completed nearly $30 million in closed transactions during its first full quarter of operations....
-

Clover Introduces Identity-Based Payments to Transform Everyday Transactions

MILWAUKEE--(BUSINESS WIRE)--Clover, the all-in-one commerce solution from Fiserv (NASDAQ: FISV), a leading global provider of payments and financial services technology, today announced a collaboration with Wink, the multimodal biometric identity and payments platform. This first-of-its-kind collaboration integrates Wink’s award-winning face and palm payments technology with advanced identity and intelligence layers directly into the Clover platform. The integration marks a significant transiti...
-

Navan to Participate in the Needham Growth Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ:NAVN), the leading all-in-one business travel, payments, and expense management platform, today announced that Ariel Cohen, co-founder and CEO, will participate in a fireside chat at the Needham Growth Conference on Tuesday, January 13, 2026, at the Lotte NY Palace Hotel in New York, New York. The presentation is scheduled to begin at 10:15am ET with a live webcast and a replay accessible from the Navan investor relations website at investors.na...
-

Wipro Limited to Announce Results for the Third Quarter Ended December 31, 2025, on January 16, 2026

EAST BRUNSWICK, N.J. & BENGALURU, India--(BUSINESS WIRE)--Wipro Limited will announce results for the third quarter ended December 31, 2025, on Friday, January 16, 2026....
-

UK Debt Management Office UK Regulatory Announcement: Issue of Debt

LONDON--(BUSINESS WIRE)--  DMO-TAS067/3608/001   The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk         A002\26 7 January 2026   PRESS NOTICE   RESULT OF THE POST-AUCTION OPTION FACILITY 4⅛% TREASURY GILT 2031   An additional £946.874 million nominal of 4⅛% Treasury Gilt 2031 (ISIN Code: GB00BVP99673) will be created for settlement on 08 January 2026 in respect of the amount purchased by the Gilt-edged Market Makers and investors during the Post-A...
-

Prudential Financial, Inc. to Announce Fourth Quarter 2025 Earnings; Schedules Conference Call

NEWARK, N.J.--(BUSINESS WIRE)--Prudential Financial, Inc. (NYSE: PRU) will release its fourth quarter 2025 earnings on Tuesday, February 3, 2026, after the market closes. The earnings release, earnings presentation, financial supplement, and related materials will be posted on the company’s Investor Relations website at investor.prudential.com. Members of Prudential’s senior management will host a conference call on Wednesday, February 4, 2026, at 11:00 a.m. ET to review these results. Conferen...
-

Acme Smoked Fish Announces Appointment of Rob Snyder as Chief Executive Officer

BROOKLYN, N.Y.--(BUSINESS WIRE)--Acme Smoked Fish Corp., a leading producer of premium smoked and cured seafood since 1906, today announced that Rob Snyder has officially assumed the role of Chief Executive Officer, effective January 1, 2026. Snyder succeeds Eduardo Carbajosa, who has retired following nearly two decades of leadership with the company. Snyder has spent the past six months leading strategic planning and operational alignment across Acme’s U.S. headquarters and international oper...
-

Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States....
-

BTIG Announces Strategic Hire for TMT Investment Banking

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Sasson Darwish has joined the firm as a Managing Director and Co-Head of TMT Investment Banking, alongside Brett Fodero and Steven Marder. This hire underscores BTIG’s long-term commitment to growing its Investment Banking practice—particularly within TMT—while continuing to deliver innovative advisory and capital markets solutions to clients. Mr. Darwish brings more than 25 years of investment banking and corporate leadership experience to B...
-

Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the submission of its clinical trial application (CTA) for Study SRP-1005-101, also known as INSIGHTT, to Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. Pending approval, Sarepta expects to initiate this first-in-human clinical trial of SRP-1005 (formerly ARO-HTT) in the second quarter of 2026. SRP-1005 is an investiga...